Featured
Durvalumab + FLOT approved in England
Durvalumab + FLOT has been approved for people with stage 1b-3 operable stomach cancer on the NHS in England. SCUK represented patients and caregivers in the NICE appraisal process.
News
Stay up to date with our latest news, research highlights and developments in our work. This is where we share key updates from Stomach Cancer UK and the wider stomach cancer community
Featured
Zolbetuximab approved in Scotland
Zolbetuximab, a new treatment for stomach cancer has been approved for use in NHS Scotland
NICE appraisal of durvalumab + FLOT
Durvalumab + FLOT, if approved, will be the first opportunity for people with operable stomach and junction cancer to receive immunotherapy. Learn how SCUK has been involved.
Stand Up To Cancer
SCUK community member, Chloe Sterling is on Channel 4 news, as part of Stand Up to Cancer